Sign in

CIK 0001894525 · <br>Emerging growth company

Apimeds Pharmaceuticals US, Inc.

Sign in to watch
Ticker
APUS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851099700
Phone
848-201-5010
Business address
100 MATAWAN RD, SUITE 325, MATAWAN, NJ, 07747
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award Chairman and CMO acquired 250,000 shares (grant or award)
  3. 4 Grant or award Chief Executive Officer acquired 750,000 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy Chairman and CMO bought 27,500 shares at an average $1.83 ($50,359)
  7. 4 Open-market buy Director bought 28,500 shares at $1.99 ($56,715)
  8. 4 Open-market buy 10% owner bought 500,000 shares at $4.00 ($2,000,000)
  9. 3/A Insider 3/A
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership

Page 2 of 2 · 38 filings